Cargando…
Surfactant Status and Respiratory Outcome in Premature Infants Receiving Late Surfactant Treatment
BACKGROUND: Many premature infants with respiratory failure are deficient in surfactant, but the relationship to occurrence of bronchopulmonary dysplasia (BPD) is uncertain. METHODS: Tracheal aspirates were collected from 209 treated and control infants enrolled at 7–14 days in the Trial of Late Sur...
Autores principales: | Ballard, Philip L, Keller, Roberta L., Truog, William E., Chapin, Cheryl, Horneman, Hart, Segal, Mark R., Ballard, Roberta A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377352/ https://www.ncbi.nlm.nih.gov/pubmed/30140069 http://dx.doi.org/10.1038/s41390-018-0144-3 |
Ejemplares similares
-
Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study
por: Keller, Roberta L., et al.
Publicado: (2012) -
Composition and origin of lung fluid proteome in premature infants and relationship to respiratory outcome
por: Ballard, Philip L., et al.
Publicado: (2020) -
Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant
por: Ballard, Philip L., et al.
Publicado: (2021) -
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)
por: McEvoy, Cindy T., et al.
Publicado: (2020) -
The hydrocortisone-responsive urinary metabolome of premature infants
por: Torgerson, Dara, et al.
Publicado: (2023)